361 Capital »

Amphastar Pharmaceuticals shares owned by 361 Capital

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by 361 Capital from 13F filings

Historical chart of 361 Capital investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by 361 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by 361 Capital

Quarter filed Position value Share count Share price at filing
2020-06-30 $822k 37k 22.45

More positions owned by 361 Capital

Schwab International Equity Et Intl Eqty Etf (SCHF)
Schwab U.s. Tips Etf Us Tips Etf (SCHP)
Schwab Emerging Markets Equity Emrg Mkteq Etf (SCHE)
Spdr Blmbg Barclays Inv Grd Fl Blomberg Brc Inv (FLRN)
Schwab U.s. Large-cap Etf Us Lrg Cap Etf (SCHX)
Schwab U.s. Reit Etf Us Reit Etf (SCHH)
Schwab U.s. Mid Cap Etf Us Mid-cap Etf (SCHM)
Cadence Design Systems (CDNS)
Deckers Outdoor Corporation (DECK)
Berry Plastics (BERY)
Howmet Aerospace (HWM)
Clorox Company (CLX)
Lear Corp Com Cl A (LEA)
AutoZone (AZO)
Dish Network Corp Cl A

View all positions for 361 Capital

Top funds holding Amphastar Pharmaceuticals

BlackRock
Vanguard Group
TD Asset Management
Federated Investors
Neuberger Berman Group
State Street Corporation
Pacer Advisors
Hanna Zanoni
Epoch Investment Partners
Dimensional Fund Advisors
Btim
Geode Capital Management
American Century Companies
Northern Trust
T. Rowe Price Associates

View all funds holding Amphastar Pharmaceuticals